Kynam Capital Management, LP Nektar Therapeutics Put Options Transaction History

Kynam Capital Management, LP

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $634,000 - $1.23 Million	-200,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $832,000 - $2.74 Million	200,000 New	200,000 $260,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.